Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AURA CVE:GPH NYSEMKT:IGC NYSE:MRK On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAURAAura Biosciences$5.90-4.4%$6.57$4.34▼$12.38$366.51M0.45222,055 shs83,312 shsGPHGraphite OneC$0.93+6.9%C$0.85C$0.64▼C$1.14C$149.78M1.380765117,975 shs393,055 shsIGCIGC Pharma$0.40+21.1%$0.39$0.25▼$0.48$36.34M1.08913,992 shs214,616 shsMRKMerck & Co., Inc.$77.75-2.4%$82.63$73.31▼$114.79$194.33B0.3714.99 million shs9.57 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAURAAura Biosciences-0.80%+1.15%-5.37%-1.91%-32.20%GPHGraphite One+14.47%+24.29%+12.99%+22.54%+16.00%IGCIGC Pharma+1.75%-1.21%+8.82%+31.72%+19.01%MRKMerck & Co., Inc.-0.33%-1.84%-6.80%+0.87%-30.74%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAURAAura Biosciences$5.90-4.4%$6.57$4.34▼$12.38$366.51M0.45222,055 shs83,312 shsGPHGraphite OneC$0.93+6.9%C$0.85C$0.64▼C$1.14C$149.78M1.380765117,975 shs393,055 shsIGCIGC Pharma$0.40+21.1%$0.39$0.25▼$0.48$36.34M1.08913,992 shs214,616 shsMRKMerck & Co., Inc.$77.75-2.4%$82.63$73.31▼$114.79$194.33B0.3714.99 million shs9.57 million shsThe 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAURAAura Biosciences-0.80%+1.15%-5.37%-1.91%-32.20%GPHGraphite One+14.47%+24.29%+12.99%+22.54%+16.00%IGCIGC Pharma+1.75%-1.21%+8.82%+31.72%+19.01%MRKMerck & Co., Inc.-0.33%-1.84%-6.80%+0.87%-30.74%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAURAAura Biosciences 3.00Buy$22.00272.88% UpsideGPHGraphite One 0.00N/AN/AN/AIGCIGC Pharma 3.00Buy$3.88881.01% UpsideMRKMerck & Co., Inc. 2.33Hold$106.4136.87% UpsideCurrent Analyst Ratings BreakdownLatest MRK, GPH, IGC, and AURA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/17/2025MRKMerck & Co., Inc.Berenberg BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold$100.00 ➝ $90.008/19/2025AURAAura BiosciencesZacks ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong Sell ➝ Hold8/13/2025AURAAura BiosciencesHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$22.007/30/2025MRKMerck & Co., Inc.Wells Fargo & CompanySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$97.00 ➝ $90.007/10/2025MRKMerck & Co., Inc.Morgan StanleySubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetEqual Weight$99.00 ➝ $98.00(Data available from 9/25/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAURAAura BiosciencesN/AN/AN/AN/A$3.04 per shareN/AGPHGraphite OneN/AN/AC$0.01 per share94.17C$0.44 per shareN/AIGCIGC Pharma$1.33M27.03N/AN/A$0.08 per share4.94MRKMerck & Co., Inc.$63.62B3.05$9.20 per share8.45$18.33 per share4.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAURAAura Biosciences-$86.92M-$1.96N/AN/AN/AN/A-64.44%-54.24%11/11/2025 (Estimated)GPHGraphite One-C$4.90M-C$0.06N/A∞N/AN/A-10.96%-6.61%N/AIGCIGC Pharma-$13M-$0.07N/AN/AN/A-714.16%-122.44%-88.40%N/AMRKMerck & Co., Inc.$17.12B$6.4911.997.850.8225.79%41.05%16.55%10/30/2025 (Estimated)Latest MRK, GPH, IGC, and AURA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/13/2025Q2 2025AURAAura Biosciences-$0.49-$0.47+$0.02-$0.47N/AN/A7/29/2025Q2 2025MRKMerck & Co., Inc.$2.03$2.13+$0.10$1.76$15.92 billion$15.81 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAURAAura BiosciencesN/AN/AN/AN/AN/AGPHGraphite OneN/AN/AN/AN/AN/AIGCIGC PharmaN/AN/AN/AN/AN/AMRKMerck & Co., Inc.$3.244.17%N/A49.92%14 YearsLatest MRK, GPH, IGC, and AURA DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/22/2025MRKMerck & Co., Inc.quarterly$0.814%9/15/20259/15/202510/7/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAURAAura BiosciencesN/A12.3912.39GPHGraphite One0.021.090.33IGCIGC Pharma0.021.150.98MRKMerck & Co., Inc.0.691.421.17Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAURAAura Biosciences96.75%GPHGraphite One0.21%IGCIGC Pharma3.87%MRKMerck & Co., Inc.76.07%Insider OwnershipCompanyInsider OwnershipAURAAura Biosciences6.30%GPHGraphite One28.81%IGCIGC Pharma23.66%MRKMerck & Co., Inc.0.13%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAURAAura Biosciences5062.12 million58.21 millionNot OptionableGPHGraphite One20161.05 millionN/ANot OptionableIGCIGC Pharma6190.81 million54.60 millionN/AMRKMerck & Co., Inc.75,0002.50 billion2.49 billionOptionableMRK, GPH, IGC, and AURA HeadlinesRecent News About These CompaniesMerck KGaA CEO succession plan5 hours ago | thepharmaletter.comTMerck: 25% Total Return CAGR Potential5 hours ago | seekingalpha.comHere's Why Merck (MRK) is a Strong Value StockSeptember 25 at 10:41 AM | zacks.comMerck & Co., Inc. $MRK Shares Acquired by MEAG MUNICH ERGO Kapitalanlagegesellschaft mbHSeptember 25 at 7:11 AM | marketbeat.comLittlejohn Financial Services Inc. Boosts Stake in Merck & Co., Inc. $MRKSeptember 25 at 6:51 AM | marketbeat.comPlancorp LLC Lowers Stock Position in Merck & Co., Inc. $MRKSeptember 25 at 6:42 AM | marketbeat.comSylvest Advisors LLC Grows Stock Holdings in Merck & Co., Inc. $MRKSeptember 25 at 6:41 AM | marketbeat.comRetirement Guys Formula LLC Raises Stock Holdings in Merck & Co., Inc. $MRKSeptember 25 at 6:24 AM | marketbeat.comAvaii Wealth Management LLC Invests $368,000 in Merck & Co., Inc. $MRKSeptember 25 at 6:04 AM | marketbeat.comBeacon Investment Advisory Services Inc. Has $2.46 Million Stock Holdings in Merck & Co., Inc. $MRKSeptember 25 at 5:28 AM | marketbeat.comHarrell Investment Partners LLC Sells 55,727 Shares of Merck & Co., Inc. $MRKSeptember 25 at 5:27 AM | marketbeat.comTD Private Client Wealth LLC Trims Stock Position in Merck & Co., Inc. $MRKSeptember 25 at 4:59 AM | marketbeat.comVerona Pharma Shareholders Approve Merck AcquisitionSeptember 25 at 4:50 AM | tipranks.comVerona Pharma Shareholders Approve Merck Acquisition Proposal for $10 Billion TransactionSeptember 24 at 4:30 PM | quiverquant.comQJP Morgan Says Economy Slowing Fast: 5 High-Yield Value Stock Fall BuysSeptember 24 at 4:13 PM | 247wallst.comMerck's Keytruda gets an upgradeSeptember 24 at 2:13 PM | youtube.comYFoster Victor Wealth Advisors LLC Has $9.83 Million Position in Merck & Co., Inc. $MRKSeptember 24 at 7:16 AM | marketbeat.comPublic Employees Retirement System of Ohio Reduces Holdings in Merck & Co., Inc. $MRKSeptember 24 at 7:06 AM | marketbeat.comMerck & Co., Inc. $MRK Holdings Raised by Northside Capital Management LLCSeptember 24 at 6:37 AM | marketbeat.comIMS Capital Management Buys New Shares in Merck & Co., Inc. $MRKSeptember 24 at 6:36 AM | marketbeat.comBallentine Partners LLC Has $3.86 Million Position in Merck & Co., Inc. $MRKSeptember 24 at 6:25 AM | marketbeat.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMRK, GPH, IGC, and AURA Company DescriptionsAura Biosciences NASDAQ:AURA$5.90 -0.27 (-4.44%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Aura Biosciences, Inc., a clinical-stage biotechnology company, develops precision immunotherapies to treat a range of solid tumors. The company's proprietary platform enables the targeting of a range of solid tumors using virus-like particles conjugated with drugs or loaded with nucleic acids to create virus-like drug conjugates. Its lead candidate is bel-sar, which is in late-stage clinical development for the treatment of patients with primary choroidal melanoma and other ocular oncology indications, as well as in early-stage clinical development in bladder cancer. The company also focuses on assessing the safety and efficacy of bel-sar in treating a range of other solid tumors, including bladder cancer as an alternative to bacillus calmetteguérin therapy. Aura Biosciences, Inc. was incorporated in 2009 and is headquartered in Boston, Massachusetts.Graphite One CVE:GPHC$0.93 +0.06 (+6.90%) As of 03:21 PM EasternGraphite One Inc. operates as mineral exploration company in the United States. The company holds interest in the Graphite Creek property that consists of 135 mining claims located on the Seward Peninsula, Alaska. The company was formerly known as Graphite One Resources Inc. and changed its name to Graphite One Inc. in February 2019. Graphite One Inc. was incorporated in 2006 and is headquartered in Vancouver, Canada.IGC Pharma NYSEMKT:IGC$0.40 +0.07 (+21.44%) As of 03:50 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.IGC Pharma, Inc., a clinical stage pharmaceutical company, engages in developing treatments for Alzheimer's disease. The company's lead product is IGC-AD1, which is in a Phase 2B clinical trial as a treatment for agitation in dementia due to Alzheimer's; and TGR-63, IGC-1C, IGC-M3, and LMP in pre-clinical development. The company was formerly known as India Globalization Capital, Inc. and changed its name to IGC Pharma, Inc. in March 2023. The company was incorporated in 2005 and is headquartered in Potomac, Maryland.Merck & Co., Inc. NYSE:MRK$77.75 -1.92 (-2.41%) As of 03:51 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas It's a Good Time to Build a Position in KB Home Cintas Stock Sends a Clear Buy Signal as Momentum Builds Micron’s Stock Price Rally Is Not Over: MU $190 Is Coming Soon NuScale Power: The SMR Stock at the Heart of the AI Energy Boom Intel + NVIDIA: The Unexpected AI Alliance Shaking Wall Street Why Traders Are Doubling Down on SoundHound Stock After Big Rally Spotify Could Surge Higher—Here’s the Hidden Earnings Signal Qualcomm’s RSI Just Hit Its High of the Year—Why That’s Bullish Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
